Nilotinib Patent Expiry Leaves Door Open For India Generics, Other Markets Could Face Longer Wait

Hetero Likely Planning India Generic

 
• By Vibha Ravi
Nilotinib
A Generic To Tasigna Is Much Awaited • Source: Shutterstock

More from Business

More from Scrip